Stay updated on BMS-986205 and Nivolumab in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page.

Latest updates to the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page revision label was updated from v3.4.0 to v3.4.1, indicating a minor maintenance update that does not affect the study details.SummaryDifference0.1%

- Check27 days agoChange DetectedAdded a glossary toggle and displayed a new 'Last Update Submitted that Met QC Criteria' label, along with a 'No FEAR Act Data' notice and a 'Revision: v3.4.0' marker. Removed the older 'Last Update Submitted that met QC Criteria', the 'No FEAR Act data' label, and the 'Revision: v3.3.4' marker.SummaryDifference0.2%

- Check41 days agoChange DetectedAdded revision: v3.3.4 and removed v3.3.3, a minor maintenance update with no impact on study content or user interactions.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a Locations section listing California as a site. Removed the California Locations entry and the HHS Vulnerability Disclosure link; updated the revision to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedRevision: v3.3.2 replaces v3.2.0 on the page, indicating a system update. This appears to be a background update with no changes to the study details or how users interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to BMS-986205 and Nivolumab in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page.